SHPA Home

Members seeking information regarding the H1N1 Influenza Outbreak are recommended to check the Department of Health and Ageing (DOHA) website and their local Department of Health website for updated information. The following links are provided for assistance: 

Department of Health and Ageing (DOHA)

• DOHA H1N1 Influenza Outbreak website 
• H1N1 Influenza Fact Sheel (DOHA)
• Useful information for health professionals  
• Update Bulletins 

Jurisdictional links:

For specific information regarding your state or territory please check the following links – should Branches have any additional Health Department links they would like included please advise SHPA. 

ACT - http://www.health.act.gov.au/c/health?a=&did=11044035 
 
NSW - http://www.emergency.health.nsw.gov.au/swineflu/index.asp 
 
NT - http://www.health.nt.gov.au/Centre_for_Disease_Control/index.aspx 
 
Qld - http://www.health.qld.gov.au/swineflu/ 
 
SA - http://www.flu.sa.gov.au/Swineflu.aspx 
 
Tas - http://www.pandemic.tas.gov.au/ 
 
Vic - http://health.vic.gov.au/ideas/diseases/swine-influenza
http://humanswineflu.health.vic.gov.au/practitioners/index.htm
 
WA - http://www.health.wa.gov.au/swine_flu/home/ 

Oseltamivir (Tamiflu)

Roche Products Australia
Roche Products Australia is working with the Federal Government and other stakeholders including relevant health authorities in the provision of antiviral medication as required. 

The Tamiflu website provides up-to-date information about oseltamivir but is for access by health professionals only.  Download this document  for access to the link and password (members only).

Tamiflu Update - May 2010
Tamiflu dosing administration update for hospitals - 5 June 2009 


Paediatric Dosing
There have been several questions regarding use of oseltamivir (Tamiflu) in infants less than 12 months of age. It is noted that the current TGA product approval and information of oseltamivir is for children greater than 1 year of age. Information on this issue can be read in an opinion from the European Medicines Agency website at: http://www.emea.europa.eu/humandocs/PDFs/EPAR/tamiflu/27883809en.pdf. Alternatively enquiries could be directed to major paediatric hospitals in your jurisdiction (for example in Victoria at the Royal Children’s Hospital information can be found at http://www.rch.org.au/clinicalguide/cpg.cfm?doc_id=12820) . It should be noted that the current oseltamivir (Tamiflu) suspension provides an oral syringe which is calibrated in 30, 45, 60 and 75 mg dosages, should smaller doses be required a normal 3 or 5 mL syringe should be provided.

H1N1 Vaccine (Panvax)

Go to this page on the Australian Prescriber website for independent information about the recently released H1N1 vaccine from CSL.